Document is current
Any future updates will be listed below
-
Authors
Mansour, Ahmad M.
Ashraf, Mohammed
El Jawhari, Khalil M.
Farah, Michel https://orcid.org/0000-0001-5951-0193
Souka, Ahmed
Sarvaiya, Chintan
Singh, Sumit Randhir
Banker, Alay
Chhablani, Jay
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02486484 at ClinicalTrials.govDocuments that mention this clinical trial
Three-month outcome of ziv-aflibercept for exudative age-related macular degeneration
https://doi.org/10.1136/bjophthalmol-2015-308319
Intravitreal ziv-aflibercept in diabetic vitreous hemorrhage
https://doi.org/10.1186/s40942-019-0204-9
- License Information
-
More Information
Article History
Received: 2 August 2019
Accepted: 9 December 2019
First Online: 14 January 2020
Ethics approval and consent to participate
: Ethics approval and consent were obtained from the Institutional Review Boards at each site and registered as NCT 02486484 (ClinicalTrials.gov<b>).</b>
: Not applicable.
: “The authors declare that they have no competing interests.
